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As the ability of highly active antiretroviral therapy
(HAART) to suppress virus in a durable and safe manner
improves, the inability of HAART to fully restore a normal
immune system may emerge as the primary limitation of
therapy. Among individuals who initiate HAART at a CD4
cell count <200 and who exhibit a potent and durable
virologic response, only 50% are able to achieve normal
peripheral CD4+ T cell within the first 10 years of therapy.
The inability to restore CD4+ T cell numbers is predicted
and perhaps caused by persistent T cell activation on ther-
apy, which in turn may be due to residual HIV replication,
persistent microbial translocation, poorly controlled co-
infections and/or other mechanisms. Although long-term
treated patients with suppressed virus are at low risk for
AIDS-related complications, they remain at high risk for
significant non-AIDS morbidity, particularly premature
cardiovascular disease. Many of these non-AIDS compli-
cations are known to be associated with and perhaps
caused by chronic inflammation. These data suggest that
persistent inflammation during HAART will emerge as pri-
mary factor limiting the long-term effectiveness of ther-
apy.
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